We have a pipeline of transformative small molecule therapies to treat multiple #CNS disorders, including #majordepressivedisorder and #bipolardisorder depression. With our recent Series C financing, we are advancing these treatments in the clinic to help patients suffering with these conditions. Read more about our progress here: https://lnkd.in/gnzrDDn2
Autobahn Therapeutics, Inc.’s Post
More Relevant Posts
-
Today is Ehlers-Danlos Syndrome (EDS) Awareness Day! What is EDS? EDS is a group of heritable connective tissue disorders. People with EDS struggle with frequent injuries and chronic pain, among many other systemic symptoms. These treatment plans can be complex and usually require a combination of: 🔸 Analgesic therapeutics 🔸 Physical therapy 🔸 Light touch body work 🔸 Mind-body therapies A patient's perception of pain can be greatly impacted by sources of neuroinflammation. For some people, this might be an autoimmune process. For others, it can be mast cell and histamine reactions. Finding and managing these sources of inflammation can positively impact overall pain scores. 👉 What are your questions about EDS? THINKVIDA.COM #eds #edsawareness #hypermobility #ehlersdanlossyndrome #ehlersdanlossyndromeawareness #functionalmedicine #primarycare #familymedicine #seattlewa #guthealthy #autoimmunehealth #inflammationrelief
To view or add a comment, sign in
-
-
The decision to initiate systemic therapy in patients with atopic dermatitis (AD) is complex. The “When to Start Systemic Therapy Checklist” was developed to aid clinicians in identifying patients with AD who are candidates for systemic therapy. Consisting of three sections, systemic therapy is indicated when at least one criterion in each section is fulfilled. Learn more and view the checklist: https://e.lilly/49hmKSQ
To view or add a comment, sign in
-
-
Our oils support a titration model, allowing for gradual dose increases until optimal therapeutic effects are achieved. This method is particularly valuable in managing conditions such as chronic pain, anxiety and epilepsy, where precise dosing can significantly impact outcomes. Discover the full range at https://lnkd.in/eBVFZMDH Read full article 📖 https://lnkd.in/eXZcmMwD #Titration #MedicalCannabis #CannabisPatient #Clinics
To view or add a comment, sign in
-
-
Neuropathy can arise from several causes, such as diabetes, chemotherapy, and traumatic injuries. Understanding the cause is the first step to effective treatment. #NeuropathyCauses #HealthAwareness #ThompsonNeuroTherapy
To view or add a comment, sign in
-
-
Neuropathy can arise from several causes, such as diabetes, chemotherapy, and traumatic injuries. Understanding the cause is the first step to effective treatment. #NeuropathyCauses #HealthAwareness #ThompsonNeuroTherapy
To view or add a comment, sign in
-
-
Exploring the link between Type 3 Diabetes and Alzheimer's - https://bit.ly/4eUGQGu #konectar #Alzheimer #Type3Diabetes #T3D #insulinresistance
FDA has approved a treatment for Alzheimer’s disease. This treatment should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was studied in the clinical trials: https://lnkd.in/eH6wjPCx
To view or add a comment, sign in
-
-
Big news from the FDA 📣 ✅ Kisunla has just been approved with fast track, priority review, and breakthrough therapy designations to treat early stage Alzheimer's disease. It is always exciting to see new approvals with such positive clinical outcomes. #clinicalresearch #regulatoryapproval #FDA #alzheimersdisease #GSCTS
FDA has approved a treatment for Alzheimer’s disease. This treatment should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was studied in the clinical trials: https://lnkd.in/eH6wjPCx
To view or add a comment, sign in
-
-
That what s a Real Medical Device Compamy must provide. The purpose is known and set since More than 30 years
We are thrilled to share this clinical case with you! 🙌💪 This success story involves an 81-year-old male patient with Parkinson's Disease who showed significant improvement after undergoing 10 sessions of Radial Shockwave therapy. 🔢 Number of sessions: 10 📅 Session frequency: Twice a week 🎯 Application areas: Upper and lower limbs 💊 Therapeutic dose: 10Hz, 3 bars, 2000 shocks per limb and cervical area This case exemplifies the potential benefits of Radial Shockwave therapy in managing symptoms of Parkinson's Disease, highlighting our commitment to innovative and effective treatments.
To view or add a comment, sign in
-
In this case series of patients with Child-Pugh class B liver dysfunction, immunotherapy-based systemic therapy was associated with reduction in the risk of death compared with best supportive care. https://ja.ma/3LsTGy7
To view or add a comment, sign in
-
-
🎥 NEW VIDEO! In this video, Gail Roboz, physician at Weill Cornell Medicine and Know AML ambassador, addresses concerns around side effects in clinical trials. #KnowAML #AcuteMyeloidLeukemia #leukemia
To view or add a comment, sign in